Hypofractionated radiotherapy compared with conventionally fractionated radiotherapy to treat initial distant metastases in nasopharyngeal carcinoma: A multicenter, prospective, randomized, phase II trial

医学 鼻咽癌 粘膜炎 临床终点 危险系数 内科学 放射治疗 随机对照试验 置信区间 胃肠病学 前瞻性队列研究 化疗 外科
作者
Jian Liu,Bin Zhang,Yixin Su,Guanjie Qin,Xiangyun Kong,Yunyan Mo,Rongjun Zhang,Wei Jiang
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:187: 109815-109815 被引量:3
标识
DOI:10.1016/j.radonc.2023.109815
摘要

To investigate the safety and efficacy of hypofractionated plus chemotherapy in patients with initially distant metastatic nasopharyngeal carcinoma (mNPC).Between May 2014 and June 2020, 35 patients initially diagnosed with mNPC were enrolled on prospective trial. The enrolled patients were assigned randomly to receive either hypofractionated plus chemotherapy (HFRT) or conventionally fractionated radiotherapy plus chemotherapy (CFRT). 60 Gy over 25 fractions was administered to the HFRT group (n = 17) and 69.96 Gy over 33 fractions was administered to the CFRT group (n = 18), both groups five times each week.Progression free survival (PFS) comprised the primary endpoint. Overall survival (OS), locoregional relapse-free survival (LRRFS), distant metastasis-free survival (DMFS), and acute and late toxicity comprised the secondary endpoints.Twenty-eight patients (seven were excluded) were enrolled. The 2-year PFS was 33.3% (HFRT group) versus 30.0% (CFRT group) (stratified hazard ratio (HR):1.09; 95% confidence interval (CI): 0.45-2.65, P = 0.843). The 2-year OS was 66.7% (HFRT group) versus with 62.5% (CFRT group) (stratified HR, 0.88; 95% CI; 0.31-2.51, P = 0.806). All patients experienced acute grade 1 or 2, skin toxicity, oral mucositis, difficulty swallowing, xerostomia, but no acute grade 3 or 4 toxicities. All patients had grade 1 late xerostomia. Two patients experienced hearing loss in the HFRT group (one grade 1 and one grade 3), and three patients experienced grade 1 hearing loss in the CFRT group. One patient developed mucosal necrosis in the HFRT group.Improving the balance between severe late toxicities and local control by appropriately reducing the total dose but increasing the fractionated dose has marked clinical significance for those patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小二郎的应助被Ari_Kun采纳,获得10
1秒前
梦欢完成签到,获得积分10
1秒前
留下记忆完成签到,获得积分10
2秒前
2秒前
3秒前
4秒前
4秒前
渤哥发布了新的文献求助10
4秒前
4秒前
5秒前
留下记忆发布了新的文献求助10
5秒前
5秒前
在水一方的应助被黎明采纳,获得10
6秒前
阳光的冷霜完成签到,获得积分10
7秒前
ml完成签到,获得积分10
8秒前
8秒前
zzz发布了新的文献求助10
8秒前
hxr发布了新的文献求助10
8秒前
三告发布了新的文献求助10
8秒前
Fu发布了新的文献求助10
8秒前
9秒前
wwwying完成签到,获得积分10
9秒前
10秒前
美满夏寒发布了新的文献求助10
10秒前
10秒前
寻欢完成签到,获得积分10
11秒前
猫不理解完成签到,获得积分20
11秒前
比山稳发布了新的文献求助10
12秒前
Lucas的应助被lyj采纳,获得10
12秒前
12秒前
酷波er的应助被优秀的荔枝采纳,获得10
13秒前
顾矜的应助被桃博采纳,获得10
13秒前
科研通AI6.3的应助被红雨灰衣采纳,获得10
13秒前
14秒前
14秒前
14秒前
15秒前
寻欢发布了新的文献求助10
15秒前
欢呼的雁芙完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177849
求助须知:如何正确求助?哪些是违规求助? 9568641
关于积分的说明 21800145
捐赠科研通 7772473
什么是DOI,文献DOI怎么找? 3432537
关于科研通互助平台的介绍 2556720
邀请新用户注册赠送积分活动 2478067